MAM
CDMO

Martingale Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Martingale Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,231
Closed -$212K – 947
2021
Q2 		$212K Sell
8,231
-7,104
-46% -$152K ﹤0.01% 794
2021
Q1 		$280K Buy
+15,335
New +$255K ﹤0.01% 761
2020
Q1 		– Sell
-10,633
Closed -$82K – 1038
2019
Q4 		$82K Buy
+10,633
New +$62K ﹤0.01% 956

Other funds holding CDMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Martingale Asset Management's CDMO Position: Q3 2021 in Review

Martingale Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2021, closing a stake of 8,231 shares — an estimated $212K sold.

Martingale Asset Management first reported a position in CDMO in Q4 2019 and held it in 3 quarters. The position peaked at $280K in Q1 2021. 161 funds tracked by Wall St. Rank hold CDMO as of Q3 2021.

  • Martingale Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Martingale Asset Management sold 8,231 Avid Bioservices, Inc. Common Stock shares in Q3 2021, an estimated $212K.
  • Martingale Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Martingale Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $280K in Q1 2021.
  • 161 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2021.

Based on Martingale Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.